Literature DB >> 11172406

Unconventional therapy use among children with cancer in Saskatchewan.

J Bold1, A Leis.   

Abstract

The study aimed to estimate the prevalence of unconventional therapy use among children with cancer in Saskatchewan, including identification of the most commonly used therapies, and to describe families' expectations and experiences in doing so. Researchers used a cross-sectional survey design with semi-structured telephone interviews to suit the descriptive and exploratory inquiry and the population focus. The personal telephone interviews occurred during the fall and winter of 1996 to 1997, with the parents coming from a wide range of geographic areas in the province of Saskatchewan. Parents of all children who were aged 14 years or younger when diagnosed with cancer during 1994 and 1995 in Saskatchewan and still living at the time of the study were identified through the provincial cancer registry with the assistance of the Saskatchewan Cancer Agency. Of the 44 families participating (92% of those eligible), 36% reported using unconventional therapy for their child's cancer; another 21% considered it. Reasons included complementing medical treatment, coping with side effects; making the child stronger; and stopping the cancer. Experiences were generally positive. Reasons for not using unconventional therapies included the child doing well and parents placing confidence in the medical system. Parents identified a need for better quality information about unconventional therapies. Unconventional therapies play a substantial complementary role in cancer care for children. Families need support to identify safe and potentially helpful therapies when they choose that route. This requires: more research about therapies' effectiveness; more accessible, quality information; and more training for health professionals in understanding and discussing unconventional therapies. There is considerable research showing that use of unconventional therapies, also known as complementary or alternative therapies, is high among adult cancer patients. Although it is likely reasonable to assume this may also be true for children, there is almost no research on children's use of unconventional therapies for cancer. Knowing the extent of children's use of unconventional therapies and whether those experiences have been beneficial or harmful is essential for parents and health professionals making quality care decisions for children.

Entities:  

Mesh:

Year:  2001        PMID: 11172406     DOI: 10.1177/104345420101800103

Source DB:  PubMed          Journal:  J Pediatr Oncol Nurs        ISSN: 1043-4542            Impact factor:   1.636


  9 in total

1.  Traumeel S in preventing and treating mucositis in young patients undergoing SCT: a report of the Children's Oncology Group.

Authors:  S F Sencer; T Zhou; L S Freedman; J A Ives; Z Chen; D Wall; M L Nieder; S A Grupp; L C Yu; I Sahdev; W B Jonas; J D Wallace; M Oberbaum
Journal:  Bone Marrow Transplant       Date:  2012-04-16       Impact factor: 5.483

2.  High prevalence of complementary and alternative medicine use in the Dutch pediatric oncology population: a multicenter survey.

Authors:  Maartje Singendonk; Gert-Jan Kaspers; Marianne Naafs-Wilstra; Antoinette Schouten-van Meeteren; Jan Loeffen; Arine Vlieger
Journal:  Eur J Pediatr       Date:  2012-09-19       Impact factor: 3.183

3.  Perceptions about complementary and alternative medicine use among Chinese immigrant parents of children with cancer.

Authors:  Lisa Watt; Sonia Gulati; Nicola T Shaw; Lillian Sung; David Dix; Iraj Poureslami; Anne F Klassen
Journal:  Support Care Cancer       Date:  2011-02-12       Impact factor: 3.603

4.  Use of homeopathy in pediatric oncology in Germany.

Authors:  Alfred Längler; Claudia Spix; Friedrich Edelhäuser; Genn Kameda; Peter Kaatsch; Georg Seifert
Journal:  Evid Based Complement Alternat Med       Date:  2010-09-22       Impact factor: 2.629

Review 5.  Complementary and alternative medicine (CAM) and supportive care in cancer: a synopsis of research perspectives and contributions by an interdisciplinary team.

Authors:  Anne Leis; Jennifer Millard
Journal:  Support Care Cancer       Date:  2007-07-17       Impact factor: 3.603

6.  Association between complementary and alternative medicine use and prolonged time to conventional treatment among Thai cancer patients in a tertiary-care hospital.

Authors:  Adit Chotipanich; Chulaporn Sooksrisawat; Benjamabhon Jittiworapan
Journal:  PeerJ       Date:  2019-06-14       Impact factor: 2.984

7.  CAM and Pediatric Oncology: Where Are All the Best Cases?

Authors:  Denise Adams; Courtney Spelliscy; Leka Sivakumar; Paul Grundy; Anne Leis; Susan Sencer; Sunita Vohra
Journal:  Evid Based Complement Alternat Med       Date:  2013-08-25       Impact factor: 2.629

8.  Complementary and alternative medicine: a survey of its use in pediatric oncology.

Authors:  Rafiaa Valji; Denise Adams; Simon Dagenais; Tammy Clifford; Lola Baydala; W James King; Sunita Vohra
Journal:  Evid Based Complement Alternat Med       Date:  2013-11-06       Impact factor: 2.629

Review 9.  Global Use of Traditional and Complementary Medicine in Childhood Cancer: A Systematic Review.

Authors:  Caroline Diorio; Catherine G Lam; Elena J Ladas; Festus Njuguna; Glenn M Afungchwi; Katherine Taromina; Stacey Marjerrison
Journal:  J Glob Oncol       Date:  2016-11-09
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.